These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26997436)

  • 1. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
    Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
    Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphangiogenesis in lymphangioleiomyomatosis: its implication in the progression of lymphangioleiomyomatosis.
    Kumasaka T; Seyama K; Mitani K; Sato T; Souma S; Kondo T; Hayashi S; Minami M; Uekusa T; Fukuchi Y; Suda K
    Am J Surg Pathol; 2004 Aug; 28(8):1007-16. PubMed ID: 15252306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
    Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
    Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis.
    Krencz I; Sebestyen A; Papay J; Jeney A; Hujber Z; Burger CD; Keller CA; Khoor A
    Hum Pathol; 2018 Sep; 79():199-207. PubMed ID: 29885404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
    Liu NN; Zhao N; Cai N
    IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosis.
    Grzegorek I; Zuba-Surma E; Chabowski M; Janczak D; Szuba A; Dziegiel P
    Anticancer Res; 2015 Jun; 35(6):3341-51. PubMed ID: 26026094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients.
    Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K
    Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
    Kristof AS; You Z; Han YS; Giaid A
    Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
    Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
    Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
    Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
    Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of human epidermal growth factor receptor family in pulmonary lymphangioleiomyomatosis.
    Kobayashi K; Miki Y; Saito R; Adachi K; Seyama K; Okada Y; Sasano H
    Hum Pathol; 2018 Nov; 81():121-130. PubMed ID: 30030119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factors C and D induces proliferation of lymphangioleiomyomatosis cells through autocrine crosstalk with endothelium.
    Issaka RB; Oommen S; Gupta SK; Liu G; Myers JL; Ryu JH; Vlahakis NE
    Am J Pathol; 2009 Oct; 175(4):1410-20. PubMed ID: 19717640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic involvement in lymphangioleiomyomatosis.
    Glasgow CG; Taveira-Dasilva AM; Darling TN; Moss J
    Ann N Y Acad Sci; 2008; 1131():206-14. PubMed ID: 18519973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphangioleiomyomatosis: a disease involving the lymphatic system.
    Seyama K; Kumasaka T; Kurihara M; Mitani K; Sato T
    Lymphat Res Biol; 2010 Mar; 8(1):21-31. PubMed ID: 20235884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
    Clements D; Markwick LJ; Puri N; Johnson SR
    J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.
    Krymskaya VP; McCormack FX
    Annu Rev Med; 2017 Jan; 68():69-83. PubMed ID: 28099079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterisation of lymphatic endothelial cells from lung tissues affected by lymphangioleiomyomatosis.
    Nishino K; Yoshimatsu Y; Muramatsu T; Sekimoto Y; Mitani K; Kobayashi E; Okamoto S; Ebana H; Okada Y; Kurihara M; Suzuki K; Inazawa J; Takahashi K; Watabe T; Seyama K
    Sci Rep; 2021 Apr; 11(1):8406. PubMed ID: 33863980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
    Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
    J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.